Prostaglandins F

DBCAT002840Pharmacologic class

(9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. A DrugBank category of 6 drugs. 4 of them are approved.

Also known as: PGF · F, Prostaglandins
Drugs: Delprostenate
Dinoprost
Dinoprost tromethamine
Etiproston
Latanoprost acid
Unoprostone

What you can answer from here — as of October 24, 2016

6DrugsEach linked to its full drug card

Listed above

10Drug targetsEvery drug–target pair in the class, with bond type

3Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Prostaglandins F share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account